financetom
Business
financetom
/
Business
/
OGE Energy Appoints Charles Walworth as CFO; Keeps Dividend at $0.42125 a Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OGE Energy Appoints Charles Walworth as CFO; Keeps Dividend at $0.42125 a Share
Dec 4, 2024 2:40 PM

05:18 PM EST, 12/04/2024 (MT Newswires) -- OGE Energy ( OGE ) said Wednesday it appointed Charles Walworth as Chief Financial Officer, effective immediately.

Walworth has worked for OGE Energy ( OGE ) for the last 25 years and was most recently the company's treasurer.

OGE Energy ( OGE ) kept its quarterly dividend at $0.42125 a share, payable on Jan. 31 to shareholders of record on Jan. 6.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bumble to Cut Workforce by 30%, Raises Q2 Outlook; Shares Gain Pre-Bell
Bumble to Cut Workforce by 30%, Raises Q2 Outlook; Shares Gain Pre-Bell
Jun 25, 2025
09:11 AM EDT, 06/25/2025 (MT Newswires) -- Bumble (BMBL) shares were up over 15% premarket Wednesday after the company's board said it approved a reduction of about 240 roles, representing 30% of its global workforce. With the workforce reduction, the company said it expects to achieve up to $40 million in annual cost savings. The online dating app provider said...
BRIEF-Moody's fully acquires ICR Chile, solidifying its leading position in key Latin American markets
BRIEF-Moody's fully acquires ICR Chile, solidifying its leading position in key Latin American markets
Jun 25, 2025
June 25 (Reuters) - Moody's Corp: * MOODY'S FULLY ACQUIRES ICR CHILE, SOLIDIFYING ITS LEADING POSITION IN KEY LATIN AMERICAN MARKETS * MOODY'S CORP - DEAL TERMS NOT DISCLOSED Source text: Further company coverage: ...
Assembly Biosciences Says ABI-4334 Phase 1b Trial Showed 'Strong' Antiviral Activity in Chronic Hepatitis B
Assembly Biosciences Says ABI-4334 Phase 1b Trial Showed 'Strong' Antiviral Activity in Chronic Hepatitis B
Jun 25, 2025
09:12 AM EDT, 06/25/2025 (MT Newswires) -- Assembly Biosciences ( ASMB ) said Wednesday a phase 1b trial of its drug candidate ABI-4334 showed 'strong' antiviral activity in chronic hepatitis B patients. Two groups of 10 patients with different doses met the safety profile supporting once-daily oral dosing for a 28-day treatment, the company said, adding there were no serious...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved